Monteplase
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pulmonary Embolism
Conditions
Pulmonary Embolism
Trial Timeline
May 1, 2007 → Apr 1, 2008
NCT ID
NCT00442234About Monteplase
Monteplase is a approved stage product being developed by Eisai for Pulmonary Embolism. The current trial status is completed. This product is registered under clinical trial identifier NCT00442234. Target conditions include Pulmonary Embolism.
What happened to similar drugs?
20 of 20 similar drugs in Pulmonary Embolism were approved
Approved (20) Terminated (1) Active (0)
✅Arformoterol Tartrate Inhalation Solution + Arformoterol Tartrate Inhalation Solution + PlaceboSumitomo PharmaApproved
✅Arformoterol Tartrate Inhalation Solution + Tiotropium + Arformoterol and Tiotropium + PlaceboSumitomo PharmaApproved
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00442234 | Approved | Completed |
Competing Products
20 competing products in Pulmonary Embolism